SBC Medical Group Holdings Inc

SBC Medical Group Holdings Inc. is a U.S.-listed medical services company with operations centered in Japan and a management base in Irvine, California and Tokyo. Through its subsidiaries, it provides franchise and management services to cosmetic treatment centers, supporting clinic operations, branding, procurement, technology, and patient-facing services.

40,4 %

73,3 %

29,4 %

−15,5 %

3.78

3.74

— SBC Medical Group Holdings Inc
%
Franchising and management services45% Core clinic support services provided to franchisee and affiliated medical corporations.
Procurement and resale25% Medical equipment, consumables, and cosmetic products supplied to clinics for resale or use.
Rental services15% Equipment and related rental services supporting clinic openings and operations.
Technology and licensing10% Software, remote consultation tools, and licensing of brand and medical technologies.
Other services5% Ancillary services such as marketing support, booking, and facility-related assistance.

The company serves medical corporations, franchisee clinics, and related clinic operators that run cosmetic and...

  • Franchisee medical corporationsprimary

    Buy management, marketing, procurement, and brand support to run cosmetic clinics under the SBC model.

  • Related affiliated clinic operatorsprimary

    Use service contracts for clinic operations support, technology, and purchasing.

  • Independent clinicssecondary

    Receive similar management services without being part of the core franchise structure.

  • Clinic patientsprimary

    End customers of the treatment centers who drive demand for cosmetic procedures and related services.

The business is primarily conducted in Japan, where its subsidiary SBC Medical Sub supports 258 treatment centers as of...

  • •Primary operating market is Japan
  • •Supports 258 treatment centers in Japan
  • •Headquartered in Irvine, California and Tokyo
  • •Revenue and costs are largely yen-denominated
  • •Foreign exchange exposure is tied to JPY/USD movements

The company’s strategy is to expand its role as a management platform for cosmetic treatment centers, combining...

01
Grow the clinic services platformmedium-term

A larger network of supported clinics increases recurring service and procurement opportunities.

02
Deepen product and technology integrationmedium-term

Bundling software, licensing, and procurement strengthens clinic dependence on the platform.

03
Allocate capital selectivelyshort-term

Management seeks to balance growth investments with shareholder returns and liquidity needs.

The business depends on a concentrated set of related-party medical corporations and franchisee clinics, so disruptions...

high

Concentration of revenue among affiliated clinic operators

The company relies on a limited number of franchisor-franchisee and service contracts.

Scope
Six core medical corporations plus additional affiliated clinics
Materiality
high
high

Related-party governance and control limitations

Several clinic operators are related parties, but the company does not have full voting control over them.

Scope
Japanese medical corporations and general incorporated associations
Materiality
high
high

Regulatory and licensing constraints in Japan

Medical service corporations operate under Japanese medical-care rules and clinic licensing requirements.

Scope
Clinic operations, franchising, and service contracts
Materiality
high
medium

Foreign exchange volatility

Most revenues and costs are denominated in Japanese yen while reporting is in U.S. dollars.

Scope
JPY/USD translation and transaction exposure
Materiality
high
medium

Demand sensitivity in aesthetic medicine

Cosmetic procedures are discretionary and can be affected by consumer spending and competition.

Scope
Treatment center volumes and equipment demand
Materiality
medium
Revenue recognition by service line
Affects quarterly revenue mix and comparability
Foreign currency translation
Can materially change reported revenue, costs, and earnings
Related-party consolidation and disclosures
Affects consolidation judgments and disclosure quality
Estimates for assets and acquired businesses
Can affect depreciation, amortization, and impairment risk

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

CELZ · Biological Products, (No Diagnostic Substances)

Modular Medical, Inc.

MODD · Surgical & Medical Instruments & Apparatus

SELECT MEDICAL HOLDINGS CORP

Services-Hospitals

Hi-Great Group Holding Co

HIGR · Hotels & Motels

InMed Pharmaceuticals Inc.

INM · Pharmaceutical Preparations

SYNLOGIC, INC.

SYBX · Pharmaceutical Preparations

: 29.4.2026